GSTM1 and neoplasm: Furthermore, tumor location, T and N classification, tumor stage, chemotherapy (cisplatin vs. paclitaxel with carboplatin), and RT-associated dysphagia showed no significant difference and influence on Hb decrease during the six weeks of RCT.